Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor injection for infants with motor developmental delay
ChiCTR1900025720Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mouse nerve growth factor in Motor developmental delay (4 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: Gross Motor Function Measure-88, Gross Motor Function Classification System and 2 more. Started Sep 2019; status: recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
Motor developmental delay
Beyond the preview
Go deeper on ChiCTR1900025720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025720.